Drug Profile
HO 0309
Alternative Names: HO/03/09Latest Information Update: 19 Feb 2016
Price :
$50
*
At a glance
- Originator HealOr
- Class Antiulcers; Chemoprotectants
- Mechanism of Action Epithelial cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mucositis
Most Recent Events
- 19 Feb 2016 No recent reports on development identified - Phase-I/II for Mucositis in Israel (Topical)
- 14 Jul 2011 Phase-I/II clinical trials in Mucositis (CAMS, chemotherapy associated mouth sores) in Israel (Topical)